AR Signaling in Breast Cancer.

Cancers (Basel) · 2017 · PMC5366816 · PMID 28245550

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Forty-nine patients with AR-positive, HER2 amplified breast cancer were categorized as molecular apocrine subtype, and survival analysis revealed a trend toward poorer OS, though this did not reach statistical significance [ 23 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.